Changes in plasma IL4, TNFá and CRP in response to regular passive smoking at home among healthy school children in Khartoum, Sudan

African Health Sciences

Volumn 12, Issue 1, 2012, Pages 41-47

  Merghani, T H ^a   Saeed, A ^a   Alawad, A ^a  

^a UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

Children; CRP; IL4; Passive smoking; TNFa

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; PASSIVE SMOKING; TUMOR NECROSIS FACTOR;

ADOLESCENT; ARTICLE; CHILD; CHILD HEALTH; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOKINE RESPONSE; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HOME ENVIRONMENT; HUMAN; LONG TERM EXPOSURE; MALE; NORMAL HUMAN; PASSIVE SMOKING; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SMOKING HABIT; SUDAN; UPREGULATION; ADVERSE EFFECTS; BLOOD; CASE CONTROL STUDY; FEMALE; PARENT; QUESTIONNAIRE; SCHOOL; SMOKING;

ADOLESCENT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-4; MALE; PARENTS; QUESTIONNAIRES; SCHOOLS; SMOKING; TOBACCO SMOKE POLLUTION; TUMOR NECROSIS FACTOR-ALPHA; BIOMARKERS; SURVEYS AND QUESTIONNAIRES;

EID: 84859864068     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Kiernan VG. Tobacco: a history. London: Hutchison Radius; 1991.
2. Borio G. Tobacco timeline [online]. 1993 [cited 2009 Apr 12]; Available from: URL:http://www.tobacco.org/tobacco_History.html.
3. Doll R. Tobacco: A medical history. J Urban Health 1999; 76: 289-313.
4. The health consequences of smoking: Nicotine addiction: Report of the Advisory Committee of the Surgeon General of the US Public Health Service; 1988.
5. Gourlay SG, Benowitz NL. Arterio-venous difference in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray and intravenous nicotine. Clin Pharmacol Ther 1997; 62: 453-463.
6. Kapoor D, Jones TH. Smoking and hormones in health and endocrine disorders. Eur J Endocrinol 2005; 152 (4): 491-499.
7. Gidding SS, Xie X, Liu K, Manolio T, Flack J, Perkins L, Gardin J. Smoking has race/gender specific effects on resting cardiac function: the CARDIA study. Circulation 1992; 82: 877. Abstract.
8. Hoffmann D, Djordjevic MV, Hoffmann I. The changing cigarette. Prev Med 1997; 26 (4): 427-434.
9. Wasserman LR. Cigarette smoking and secondary polycythemia. JAMA 1973;224:1654-1657.
10. Valença SS, Pimenta WA, Rueff-Barroso CR, Ferreira TS, Resende AC, Moura RS, Porto LC. Involvement of nitric oxide in acute lung inflammation induced by cigarette smoke in the mouse. Nitric Oxide 2009;20(3):175-181.
11. Ronchetti R, Macri F, Ciofetta G, Indinnimeo L, Cutrera R, Bonci E, Antognoni G, Martinez FD. Increased serum IgE and increased prevalence of eosinophilia in 9 year old pupils of smoking parents. J Allergy Clin Immunol 1990; 86 (1): 400-407.
12. Kaplan MH, Volanakis JE. Interaction of Creactive protein complexes with the complement system. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polusaccharide and with the choline phosphatides lecithin and sphingomyelin. Journal of immunology 1974; 112:2135-2147.
13. Ganrot PO, Kindmark CO. C-reactive proteina phagocytosis promoting factor. Scandinavian journal of clinical and laboratory investigation 1969; 24:215-219.
14. Du Clos, Terry W. Functions of C- reactive protein. Ann Med 2000; 32: 274-278.
15. Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas J, Masoura C, Toutouzas P, Stefanadis C. Effect of exposure to second hand smoke on inflammation: the ATTICA study. Am J Med. 2004; 116: 145-150.
16. Das I. Raised C-reactive protein levels in serum from smokers. Clinica Chimica Acta 1985; 153: 9-13.
17. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB: Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Brit Med J 2000; 321:199-204.
18. Helmersson J, Larsson A, Vessby B, Basu S. Active smoking and a history of smoking are associated with enhanced prostaglandin F(2á), interleukin-6 and F2-isoprostane formation in elderly men. Atherosclerosis 2005;181,201-207.
19. Boshtam M, Abbaszadeh M, Rafiei M, Hahparian M, Boshtam M. Comparison of serum levels of CRP and uric acid in active, passive, and non-smokers. ARYA Journal 2006;2(1):1-6.
20. Byron KA, Varigos GA, Wootton AM. IL4 production is increased in cigarette smokers. Clin Exp Immunol 1994; 95(2): 333-336.
21. Flouris AD, Metsios GS, Carrillo AE, Jamurtas AZ, Gourgoulianis K, Kiropoulos T, Tzatzarakis MN, Tsatsakis AM, Koutedakis Y. Acute and Short-term Effects of Secondhand Smoke on Lung Function and Cytokine Production. American Journal of Respiratory and Critical Care Medicine 2009; 179:1029-1033.
22. Strieter, R., Kunkel, S., Bone, R. Role of Tumor Necrosis Factor-Alpha in Disease States and Inflammation. Critical Care Medicine 1993; 21 (10 Supplement): S447-S463.
23. Beuttler B, Cerami A. The biology of cachectin/TNF: A primary host response. Ann Rev Immunol 1989;7:625-655.
24. Newman I, Wilkinson PJ. Chemotactic activity of lymphotoxin and TNFá for human neutrophils. Immunol 1989;66:318-320.
25. Tappia PS, Troughton KL, Langley-Evans SC, Grimble RF. Cigarette smoking influences cytokine production and antioxidant defenses. Clin Sci (London) 1995; 88 (4): 485-489.
26. Kuschner WG, D'Alessandro A, Wong H, Blane PD. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996;9:1989-1994.
27. Pessina GP, Paulesu L, Corradeschi F, Luzzi E, Tanzini M, Aldinucci C, Stefano AD, Bocci V. Chronic cigarette smoking enhances spontaneous release of tumour necrosis factor-á from alveolar macrophages of rats. Mediators Inflamm. 1993;2(6):423-428.
28. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-á in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;153:530-534.
29. McCrea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD. Altered cytokine regulation in the lungs of cigarette smokers. Am. J. Respir. Crit. Care Med.1994;150(3):696-703.
30. Churg A, Wang RD, Tai H, Wang X, Xie C, Wright JL. Tumor necrosis factor-á drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2004; 170: 492-498.
31. Churg A, Dai J, Tai H, Xie C, Wright JL: Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med 2002, 166:849-854.
32. Sakao S, Tatsumi K, Igari H, Shino Y, Shirasawa H, Kuriyama T. Association of TNFá gene promoter polymorphism with the presence ofchronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:420-422.
33. National Center for Health Statistics, National Center for Chronic Disease Prevention and Health Promotion. Body mass index for age percentiles: Boys, 2 to 20 years. CDC Growth Charts: United states; 2000.
34. World Medical Association Medical Ethics Committee. Updating the WMA Declaration of Helsinki. Wld Med J 1999; 45:11-13
35. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J 2001;34: Suppl 50s-59s.
36. Pang B, Wang C, Weng X, Tang X, Zhang H, Niu S, Mao Y, Xin P and Huang X. Lung injury caused by passive smoking and its effects on cytokines in rats. Zhonghhua Yu Fang Yi Xue Za Zhi 2000; 34 (2): 104-105.
37. Nataraja A. Passive smoking exposure is associated with an increased risk of COPD. Thorax 2008;63:48.
38. Thun MJ, Myers DG, Day-Lally C, Namboodiri MM, Calle EE, Flanders WD, Adams SL, Heath CW. Age and the exposure-response relationships between cigarette smoking and premature death in Cancer Prevention Study II. Changes in cigarette-related disease risks and their implication for prevention and control. Smoking and Tobacco Control, Monograph 8. National Cancer Institute, NIH Publication No. 97-4213., 1997:383-475.
39. El-Nawawy A, Soliman AT, El-Azzouni O, El-Sayed A, Soheir D, El-Sayed M. Effect of Passive Smoking on Frequency of Respiratory Illnesses and Serum Immunoglobulin-E and Interleukin-4 (IL4) Concentrations in Exposed Pupils. J Trop Pediatr 1996;42(3): 166-169.
40. Oryszczyn MP, Annesi-Maesano I, Charpin D, Paty E, Maccario J, Kauffmann F. Relationships of Active and Passive Smoking to Total IgE in Adults of the Epidemiological Study of the Genetics and Environment of Asthma, Bronchial Hyperresponsiveness, and Atopy (EGEA). Am. J. Respir. Crit. Care Med. 2000;161(4):1241-1246.
41. Young B, Gleeson M, Cripps AW. C-reactive protein: a critical review. Pathology. 1991;23:118-124.
42. Ridker PM, Glynn RJ, Hennekens CH. Creactive protein adds to the predictive alue of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998; 97: 2007-2011.
43. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH.Inflammation, aspirin, and risks of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979.
44. Prescott E, Lange P, Vestbo J. Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. Eur Respir J 1999; 13: 1109-1114.
45. Jousilahti P, Salomaa V, Rasi V, Vahtera E, Palosuo T. Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status. J Epidemiol Community Health. 2003;57:730-733.
46. Owen N, Poulton T, Hay FC, Mohamed-Ali V, Steptoe A. Socioeconomic status, C-reactive protein, immune factors, and responses to acute mental stress. Brain Behav Immun. 2003;17:286-295.
47. Popko K, Gorska E, Stelmaszczyk-Emmel A, Plywaczewski R, Stoklosa A, Gorecka D, Pyrzak B, González-Martínez H, Rodríguez L, Nájera O, Cruz D, Miliar A, Domínguez A, Sánchez F, Graniel J, González-Torres MC. Expression ofCytokine mRNA in Lymphocytes of Malnourished Children. J of Clin Immunol 2008;28(5):593-599.